inner-banner

ANZICS Clinical Trials Group Annual Meeting on Clinical Trials in Intensive Care

ANZICS Clinical Trials Group 23rd Annual Meeting Program

ICU Research

Coordinator Workshop

Mon, 1st March 2021

ANZICS PSG Meeting

Tues, 2nd March 2021
held: Centre for Children’s Health Research South Brisbane QLD

 

Registrations

Accommodation

Getting There

 

The ANZICS Clinical Trials Group 23rd Annual Meeting on Clinical Trials in Intensive Care will be held from Tuesday March 2nd – Thursday March 4th 2021, at Peppers Noosa Resort & Villas, Noosa Heads, Queensland, Australia. However, with the most recent unpredictable Covid-19 climate, the meeting will be held virtually.

The ICU Research Coordinator Workshop will be held on Monday 1st March 2021. 

The ANZICS Clinical Trials Group (CTG) Annual Meeting on Clinical Trials in Intensive Care, or “Noosa”, has long been regarded as a pivotal event on the ANZICS CTG calendar. This working meeting provides a forum for the presentation, discussion, and development of intensive care research proposals, the presentation of results and updates on current ANZICS CTG studies, and didactic elements centered on the advancement of clinical research methods in critical illness. For those with an emerging or established interest in critical care research, the Noosa meeting is an opportunity to be an active member of the ANZICS CTG network and benefit from the collective experience and expertise of the trials group.

The annual ICU Research Coordinator Workshop is a unique and highly-valuable education forum and provides an opportunity for ICU Research Coordinators to network, share ideas and experiences, and further the development of research coordination as a specialised area of critical care research.

Members of the intensive care research community and individuals working in the public sector (i.e. in a non-commercial setting) to improve outcomes for people with critical illness are invited to attend the meetings.

Discount registration rates are available to individuals working in Intensive Care Units or related institutions who are members of the ANZICS Clinical Trials Group.